B Smith1, M Brochhausen. 1. Institute of Formal Ontology and Medical Information Science (IFOMIS), Universität des Saarlandes, Campus A2.4, 66123 Saarbrücken, Germany. phismith@buffalo.edu
Abstract
OBJECTIVES: Biomedical ontologies exist to serve integration of clinical and experimental data, and it is critical to their success that they be put to widespread use in the annotation of data. How, then, can ontologies achieve the sort of user-friendliness, reliability, cost-effectiveness, and breadth of coverage that is necessary to ensure extensive usage? METHODS: Our focus here is on two different sets of answers to these questions that have been proposed, on the one hand in medicine, by the SNOMED CT community, and on the other hand in biology, by the OBO Foundry. We address more specifically the issue as to how adherence to certain development principles can advance the usability and effectiveness of an ontology or terminology resource, for example by allowing more accurate maintenance, more reliable application, and more efficient interoperation with other ontologies and information resources. RESULTS: SNOMED CT and the OBO Foundry differ considerably in their general approach. Nevertheless, a general trend towards more formal rigor and cross-domain interoperability can be seen in both and we argue that this trend should be accepted by all similar initiatives in the future. CONCLUSIONS: Future efforts in ontology development have to address the need for harmonization and integration of ontologies across disciplinary borders, and for this, coherent formalization of ontologies is a pre-requisite.
OBJECTIVES: Biomedical ontologies exist to serve integration of clinical and experimental data, and it is critical to their success that they be put to widespread use in the annotation of data. How, then, can ontologies achieve the sort of user-friendliness, reliability, cost-effectiveness, and breadth of coverage that is necessary to ensure extensive usage? METHODS: Our focus here is on two different sets of answers to these questions that have been proposed, on the one hand in medicine, by the SNOMED CT community, and on the other hand in biology, by the OBO Foundry. We address more specifically the issue as to how adherence to certain development principles can advance the usability and effectiveness of an ontology or terminology resource, for example by allowing more accurate maintenance, more reliable application, and more efficient interoperation with other ontologies and information resources. RESULTS: SNOMED CT and the OBO Foundry differ considerably in their general approach. Nevertheless, a general trend towards more formal rigor and cross-domain interoperability can be seen in both and we argue that this trend should be accepted by all similar initiatives in the future. CONCLUSIONS: Future efforts in ontology development have to address the need for harmonization and integration of ontologies across disciplinary borders, and for this, coherent formalization of ontologies is a pre-requisite.
Authors: M A Harris; J Clark; A Ireland; J Lomax; M Ashburner; R Foulger; K Eilbeck; S Lewis; B Marshall; C Mungall; J Richter; G M Rubin; J A Blake; C Bult; M Dolan; H Drabkin; J T Eppig; D P Hill; L Ni; M Ringwald; R Balakrishnan; J M Cherry; K R Christie; M C Costanzo; S S Dwight; S Engel; D G Fisk; J E Hirschman; E L Hong; R S Nash; A Sethuraman; C L Theesfeld; D Botstein; K Dolinski; B Feierbach; T Berardini; S Mundodi; S Y Rhee; R Apweiler; D Barrell; E Camon; E Dimmer; V Lee; R Chisholm; P Gaudet; W Kibbe; R Kishore; E M Schwarz; P Sternberg; M Gwinn; L Hannick; J Wortman; M Berriman; V Wood; N de la Cruz; P Tonellato; P Jaiswal; T Seigfried; R White Journal: Nucleic Acids Res Date: 2004-01-01 Impact factor: 16.971
Authors: Barry Smith; Michael Ashburner; Cornelius Rosse; Jonathan Bard; William Bug; Werner Ceusters; Louis J Goldberg; Karen Eilbeck; Amelia Ireland; Christopher J Mungall; Neocles Leontis; Philippe Rocca-Serra; Alan Ruttenberg; Susanna-Assunta Sansone; Richard H Scheuermann; Nigam Shah; Patricia L Whetzel; Suzanna Lewis Journal: Nat Biotechnol Date: 2007-11 Impact factor: 54.908
Authors: Dennis G Thomas; Fred Klaessig; Stacey L Harper; Martin Fritts; Mark D Hoover; Sharon Gaheen; Todd H Stokes; Rebecca Reznik-Zellen; Elaine T Freund; Juli D Klemm; David S Paik; Nathan A Baker Journal: Wiley Interdiscip Rev Nanomed Nanobiotechnol Date: 2011-06-30
Authors: Femke Ongenae; Dries Myny; Tom Dhaene; Tom Defloor; Dirk Van Goubergen; Piet Verhoeve; Johan Decruyenaere; Filip De Turck Journal: BMC Health Serv Res Date: 2011-02-04 Impact factor: 2.655
Authors: Janna Hastings; Leonid Chepelev; Egon Willighagen; Nico Adams; Christoph Steinbeck; Michel Dumontier Journal: PLoS One Date: 2011-10-03 Impact factor: 3.240
Authors: María Taboada; Diego Martínez; Belén Pilo; Adriano Jiménez-Escrig; Peter N Robinson; María J Sobrido Journal: BMC Med Inform Decis Mak Date: 2012-07-31 Impact factor: 2.796